ACOS brings leading ophthalmologists and innovators of technologies together to advance vision care and improve patients’ quality of life.
ACOS and Avedro, Inc. jointly announce the initiation of a Phase 3 multi-center, randomized, controlled evaluation to study accelerated corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery. Read the story on EyeWire Today.
We want to thank the faculty, attendees and especially our supporters of the ACOS-Dulaney Winter Meeting that concluded last week! It was the largest attended meeting with the most supporters ever. The faculty did an outstanding job! Read the tweets below and on our ACOS twitter account for highlights from some of the presentations.
Follow the tweets below for live updates from the ACOS-Dulaney Winter Meeting!
The FDA should approve drugs based on safety and leave efficacy testing for post-marketing studies, according to an article that appeared in Tuesday's Wall Street Journal. Read the story on EyeWire Today.
The ACOS-Dulaney Winter Meeting is nearly sold out! Register today in order to attend this high-level educational meeting designed for the experienced ophthalmic surgeon.
Welcome to the new and revised ACOS Web site! We are very proud to offer this benefit to our members and visitors of ACOS. Learn more about the ACOS leadership, founding members, meetings and 2012 initiatives. Stay tuned as we continue to build our community!